ANXA1 mimetic peptide Ac2-26 alleviated the inflammation in COPD via reducing the levels of pro-inflammatory mediators and increasing anti-inflammatory cytokines [17]. Here, ANXA1 is linked to chronic obstructive pulmonary disease.